TROPHEA DEV AB has a total of 12 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2015. It filed its patents most often in United States, Australia and Brazil. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are BROWN SANDRA, DERMIPSOR LTD and CETERIS HOLDING B V AMSTERDAM.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 2 | |
#2 | Australia | 1 | |
#3 | Brazil | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Hungary | 1 | |
#8 | Israel | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Mexico | 1 | |
#11 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Specific use of cosmetics | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Batcheller Derek Gregory | 9 |
#2 | Faergemann Jan | 9 |
#3 | Johannsson Gudmundur | 9 |
#4 | Ohlsson Claes | 9 |
#5 | Törnell Jan | 4 |
#6 | Johnsson Jörgen | 4 |
#7 | Tornell Jan | 3 |
#8 | Johnsson Joergen | 2 |
#9 | Johnsson Jorgen | 2 |
#10 | Jan Törnell | 2 |
Publication | Filing date | Title |
---|---|---|
US2017319598A1 | Treatment of skin atrophy with a combination of triiodothyroacetic acid (TRIAC) and dehydroepiandrosterone (DHEA) |